We are analyzing https://link.springer.com/article/10.1007/s10585-009-9292-5.

Title:
Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients | Clinical & Experimental Metastasis
Description:
The transcription factor Twist plays a key role in cancer metastasis. The present study aimed at investigating clinical Twist expression in patients with esophageal squamous cell carcinoma (ESCC) in order to correlate the Twist levels with the patients’ survival rates and their other clinical parameters. Immunohistochemical staining using polyclonal Twist antibody was performed on paraffin embedded specimens of 112 ESCC patients and non-neoplastic esophageal epithelium used as a control. The overall staining intensity was analyzed along with clinicopathologic data and prognosis of ESCC. Twist expression was significantly higher in ESCC than in non-neoplastic oesophageal epithelium (P < 0.001). The Twist expression directly correlated with distant metastasis after esophagectomy (P = 0.001). Kaplan–Meier estimate in conjunction with the log-rank test revealed an inverse proportion relationship between postoperative survival rates of the patients and their Twist expression levels (log-rank, P < 0.001). In addition, Cox mono-variate analysis revealed that T/N classification, pTNM stage, distant metastasis and Twist expression were significantly correlated with mortality risk of patients after operation (P < 0.05). By Cox multi-variate analysis, Twist expression (risk ratio = 2.394; P < 0.001) and N classification were identified as the independent prognostic factors of patient survival. In conclusion, upregulated Twist expression in the primary ESCC significantly correlates with the high risk of subsequent development of distant metastasis and low postoperative survival rates; the latter was not significantly correlated with patients’ age, gender, tumor location and differentiation. Twist may serve as an independent prognostic marker for predicting development of distant metastasis in ESCC patients and their survival.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Movies
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

article, twist, google, scholar, cancer, pubmed, cell, cas, metastasis, carcinoma, esophageal, patients, squamous, expression, survival, prognostic, distant, escc, clinical, access, privacy, cookies, content, rates, xie, tumor, analysis, data, publish, research, search, independent, marker, predicting, significantly, cox, correlates, res, information, log, journal, fangwei, kun, ouyang, prognosis, correlated, classification, risk, factors, epithelialmesenchymal,

Topics {✒️}

month download article/chapter cox multi-variate analysis promote epithelial-mesenchymal transition neoplastic oesophageal epithelium clear cell carcinoma log-rank test revealed independent prognostic factors full article pdf independent prognostic marker tumor-related factors hepatocellular carcinoma metastasis epithelial-mesenchymal transition bile duct carcinoma leaving home early privacy choices/manage cookies esophageal carcinoma neoplastic esophageal epithelium 3q gain correlates twist overexpression correlates related subjects european economic area present study aimed paraffin embedded specimens kaplan–meier estimate inverse proportion relationship notch signaling pathway dorso-ventral pattern weinberg ra stat soc ser expression profiling reveals circle north road polyclonal twist antibody upregulated twist expression esophageal cancer conditions privacy policy check access instant access article xie article log cancer cell 13 cancer cell 14 postoperative survival rates drosophila zygotic gene twist expression levels tumor-promoting inactivation predicting distant metastasis stem cells accepting optional cookies nasopharyngeal carcinoma fuzhou general hospital

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients
         description:The transcription factor Twist plays a key role in cancer metastasis. The present study aimed at investigating clinical Twist expression in patients with esophageal squamous cell carcinoma (ESCC) in order to correlate the Twist levels with the patients’ survival rates and their other clinical parameters. Immunohistochemical staining using polyclonal Twist antibody was performed on paraffin embedded specimens of 112 ESCC patients and non-neoplastic esophageal epithelium used as a control. The overall staining intensity was analyzed along with clinicopathologic data and prognosis of ESCC. Twist expression was significantly higher in ESCC than in non-neoplastic oesophageal epithelium (P < 0.001). The Twist expression directly correlated with distant metastasis after esophagectomy (P = 0.001). Kaplan–Meier estimate in conjunction with the log-rank test revealed an inverse proportion relationship between postoperative survival rates of the patients and their Twist expression levels (log-rank, P < 0.001). In addition, Cox mono-variate analysis revealed that T/N classification, pTNM stage, distant metastasis and Twist expression were significantly correlated with mortality risk of patients after operation (P < 0.05). By Cox multi-variate analysis, Twist expression (risk ratio = 2.394; P < 0.001) and N classification were identified as the independent prognostic factors of patient survival. In conclusion, upregulated Twist expression in the primary ESCC significantly correlates with the high risk of subsequent development of distant metastasis and low postoperative survival rates; the latter was not significantly correlated with patients’ age, gender, tumor location and differentiation. Twist may serve as an independent prognostic marker for predicting development of distant metastasis in ESCC patients and their survival.
         datePublished:2009-10-09T00:00:00Z
         dateModified:2009-10-09T00:00:00Z
         pageStart:1025
         pageEnd:1032
         sameAs:https://doi.org/10.1007/s10585-009-9292-5
         keywords:
            Twist∙ esophageal squamous cell carcinoma
            Immunohistochemistry
            Prognosis
            Cancer Research
            Biomedicine
            general
            Oncology
            Hematology
            Surgical Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-009-9292-5/MediaObjects/10585_2009_9292_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-009-9292-5/MediaObjects/10585_2009_9292_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-009-9292-5/MediaObjects/10585_2009_9292_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-009-9292-5/MediaObjects/10585_2009_9292_Fig4_HTML.gif
         isPartOf:
            name:Clinical & Experimental Metastasis
            issn:
               1573-7276
               0262-0898
            volumeNumber:26
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Fangwei Xie
               affiliation:
                     name:Fuzhou General Hospital
                     address:
                        name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Kun Li
               affiliation:
                     name:Fuzhou General Hospital
                     address:
                        name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
                        type:PostalAddress
                     type:Organization
                     name:Daping Hospital
                     address:
                        name:Department of Cardiothoracic Surgery, Institute of Field Surgery, Daping Hospital, Chongqing, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xuenong Ouyang
               affiliation:
                     name:Fuzhou General Hospital
                     address:
                        name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Twist, an independent prognostic marker for predicting distant metastasis and survival rates of esophageal squamous cell carcinoma patients
      description:The transcription factor Twist plays a key role in cancer metastasis. The present study aimed at investigating clinical Twist expression in patients with esophageal squamous cell carcinoma (ESCC) in order to correlate the Twist levels with the patients’ survival rates and their other clinical parameters. Immunohistochemical staining using polyclonal Twist antibody was performed on paraffin embedded specimens of 112 ESCC patients and non-neoplastic esophageal epithelium used as a control. The overall staining intensity was analyzed along with clinicopathologic data and prognosis of ESCC. Twist expression was significantly higher in ESCC than in non-neoplastic oesophageal epithelium (P < 0.001). The Twist expression directly correlated with distant metastasis after esophagectomy (P = 0.001). Kaplan–Meier estimate in conjunction with the log-rank test revealed an inverse proportion relationship between postoperative survival rates of the patients and their Twist expression levels (log-rank, P < 0.001). In addition, Cox mono-variate analysis revealed that T/N classification, pTNM stage, distant metastasis and Twist expression were significantly correlated with mortality risk of patients after operation (P < 0.05). By Cox multi-variate analysis, Twist expression (risk ratio = 2.394; P < 0.001) and N classification were identified as the independent prognostic factors of patient survival. In conclusion, upregulated Twist expression in the primary ESCC significantly correlates with the high risk of subsequent development of distant metastasis and low postoperative survival rates; the latter was not significantly correlated with patients’ age, gender, tumor location and differentiation. Twist may serve as an independent prognostic marker for predicting development of distant metastasis in ESCC patients and their survival.
      datePublished:2009-10-09T00:00:00Z
      dateModified:2009-10-09T00:00:00Z
      pageStart:1025
      pageEnd:1032
      sameAs:https://doi.org/10.1007/s10585-009-9292-5
      keywords:
         Twist∙ esophageal squamous cell carcinoma
         Immunohistochemistry
         Prognosis
         Cancer Research
         Biomedicine
         general
         Oncology
         Hematology
         Surgical Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-009-9292-5/MediaObjects/10585_2009_9292_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-009-9292-5/MediaObjects/10585_2009_9292_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-009-9292-5/MediaObjects/10585_2009_9292_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10585-009-9292-5/MediaObjects/10585_2009_9292_Fig4_HTML.gif
      isPartOf:
         name:Clinical & Experimental Metastasis
         issn:
            1573-7276
            0262-0898
         volumeNumber:26
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Fangwei Xie
            affiliation:
                  name:Fuzhou General Hospital
                  address:
                     name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Kun Li
            affiliation:
                  name:Fuzhou General Hospital
                  address:
                     name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
                     type:PostalAddress
                  type:Organization
                  name:Daping Hospital
                  address:
                     name:Department of Cardiothoracic Surgery, Institute of Field Surgery, Daping Hospital, Chongqing, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xuenong Ouyang
            affiliation:
                  name:Fuzhou General Hospital
                  address:
                     name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Clinical & Experimental Metastasis
      issn:
         1573-7276
         0262-0898
      volumeNumber:26
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Fuzhou General Hospital
      address:
         name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
         type:PostalAddress
      name:Fuzhou General Hospital
      address:
         name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
         type:PostalAddress
      name:Daping Hospital
      address:
         name:Department of Cardiothoracic Surgery, Institute of Field Surgery, Daping Hospital, Chongqing, China
         type:PostalAddress
      name:Fuzhou General Hospital
      address:
         name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Fangwei Xie
      affiliation:
            name:Fuzhou General Hospital
            address:
               name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Kun Li
      affiliation:
            name:Fuzhou General Hospital
            address:
               name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
               type:PostalAddress
            type:Organization
            name:Daping Hospital
            address:
               name:Department of Cardiothoracic Surgery, Institute of Field Surgery, Daping Hospital, Chongqing, China
               type:PostalAddress
            type:Organization
      name:Xuenong Ouyang
      affiliation:
            name:Fuzhou General Hospital
            address:
               name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
      name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
      name:Department of Cardiothoracic Surgery, Institute of Field Surgery, Daping Hospital, Chongqing, China
      name:Department of Oncology, Fuzhou General Hospital, Fuzhou, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(99)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.47s.

LINK . SPRINGER . COM {}